Literature DB >> 26581901

Mutations in MECOM, Encoding Oncoprotein EVI1, Cause Radioulnar Synostosis with Amegakaryocytic Thrombocytopenia.

Tetsuya Niihori1, Meri Ouchi-Uchiyama2, Yoji Sasahara3, Takashi Kaneko4, Yoshiko Hashii5, Masahiro Irie2, Atsushi Sato6, Yuka Saito-Nanjo2, Ryo Funayama7, Takeshi Nagashima7, Shin-Ichi Inoue8, Keiko Nakayama7, Keiichi Ozono5, Shigeo Kure3, Yoichi Matsubara9, Masue Imaizumi6, Yoko Aoki8.   

Abstract

Radioulnar synostosis with amegakaryocytic thrombocytopenia (RUSAT) is an inherited bone marrow failure syndrome, characterized by thrombocytopenia and congenital fusion of the radius and ulna. A heterozygous HOXA11 mutation has been identified in two unrelated families as a cause of RUSAT. However, HOXA11 mutations are absent in a number of individuals with RUSAT, which suggests that other genetic loci contribute to RUSAT. In the current study, we performed whole exome sequencing in an individual with RUSAT and her healthy parents and identified a de novo missense mutation in MECOM, encoding EVI1, in the individual with RUSAT. Subsequent analysis of MECOM in two other individuals with RUSAT revealed two additional missense mutations. These three mutations were clustered within the 8(th) zinc finger motif of the C-terminal zinc finger domain of EVI1. Chromatin immunoprecipitation and qPCR assays of the regions harboring the ETS-like motif that is known as an EVI1 binding site showed a reduction in immunoprecipitated DNA for two EVI1 mutants compared with wild-type EVI1. Furthermore, reporter assays showed that MECOM mutations led to alterations in both AP-1- and TGF-β-mediated transcriptional responses. These functional assays suggest that transcriptional dysregulation by mutant EVI1 could be associated with the development of RUSAT. We report missense mutations in MECOM resulting in a Mendelian disorder that provide compelling evidence for the critical role of EVI1 in normal hematopoiesis and in the development of forelimbs and fingers in humans.
Copyright © 2015 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26581901      PMCID: PMC4678429          DOI: 10.1016/j.ajhg.2015.10.010

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  31 in total

1.  A case of congenital bone marrow failure with radio-ulnar synostosis.

Authors:  Hisao Yoshida; Yoshiko Hashii; Tokuko Okuda; Shigenori Kusuki; Emiko Sato; Akiko Inoue; Chihiro Kawakami; Miharu Yabe; Hideaki Ohta; Keiichi Ozono
Journal:  Int J Hematol       Date:  2010-01-22       Impact factor: 2.490

2.  Proximal radio-ulnar synostosis with bone marrow failure syndrome in an infant without a HOXA11 mutation.

Authors:  Paul Castillo-Caro; Santhosh Dhanraj; Paul Haut; Kent Robertson; Yigal Dror; Anjali A Sharathkumar
Journal:  J Pediatr Hematol Oncol       Date:  2010-08       Impact factor: 1.289

3.  Point mutations in two EVI1 Zn fingers abolish EVI1-GATA1 interaction and allow erythroid differentiation of murine bone marrow cells.

Authors:  Leopoldo Laricchia-Robbio; Raffaella Fazzina; Donglan Li; Ciro R Rinaldi; Kisaly K Sinha; Soumen Chakraborty; Giuseppina Nucifora
Journal:  Mol Cell Biol       Date:  2006-09-05       Impact factor: 4.272

4.  Repression of RUNX1 activity by EVI1: a new role of EVI1 in leukemogenesis.

Authors:  Vitalyi Senyuk; Kislay K Sinha; Donglan Li; Ciro R Rinaldi; Sastry Yanamandra; Giuseppina Nucifora
Journal:  Cancer Res       Date:  2007-06-15       Impact factor: 12.701

5.  Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease.

Authors:  Stefan Stein; Marion G Ott; Stephan Schultze-Strasser; Anna Jauch; Barbara Burwinkel; Andrea Kinner; Manfred Schmidt; Alwin Krämer; Joachim Schwäble; Hanno Glimm; Ulrike Koehl; Carolin Preiss; Claudia Ball; Hans Martin; Gudrun Göhring; Kerstin Schwarzwaelder; Wolf-Karsten Hofmann; Kadin Karakaya; Sandrine Tchatchou; Rongxi Yang; Petra Reinecke; Klaus Kühlcke; Brigitte Schlegelberger; Adrian J Thrasher; Dieter Hoelzer; Reinhard Seger; Christof von Kalle; Manuel Grez
Journal:  Nat Med       Date:  2010-01-24       Impact factor: 53.440

6.  EVI1 Impairs myelopoiesis by deregulation of PU.1 function.

Authors:  Leopoldo Laricchia-Robbio; Kavitha Premanand; Ciro R Rinaldi; Giuseppina Nucifora
Journal:  Cancer Res       Date:  2009-02-10       Impact factor: 12.701

7.  Donor-derived DNA in fingernails among recipients of allogeneic hematopoietic stem-cell transplants.

Authors:  Daisuke Imanishi; Yasushi Miyazaki; Reishi Yamasaki; Yasushi Sawayama; Jun Taguchi; Hideki Tsushima; Takuya Fukushima; Shinichiro Yoshida; Hiroshi Sasaki; Tomoko Hata; Masao Tomonaga
Journal:  Blood       Date:  2007-06-08       Impact factor: 22.113

8.  Evi1 is a survival factor which conveys resistance to both TGFbeta- and taxol-mediated cell death via PI3K/AKT.

Authors:  Y Liu; L Chen; T C Ko; A P Fields; E A Thompson
Journal:  Oncogene       Date:  2006-02-06       Impact factor: 9.867

Review 9.  The oncogene and developmental regulator EVI1: expression, biochemical properties, and biological functions.

Authors:  Rotraud Wieser
Journal:  Gene       Date:  2007-04-20       Impact factor: 3.688

10.  Mutation at the Evi1 locus in Junbo mice causes susceptibility to otitis media.

Authors:  Nicholas Parkinson; Rachel E Hardisty-Hughes; Hilda Tateossian; Hsun-Tien Tsai; Debra Brooker; Sue Morse; Zuzanna Lalane; Francesca MacKenzie; Martin Fray; Pete Glenister; Anne-Marie Woodward; Sian Polley; Ivana Barbaric; Neil Dear; Tertius A Hough; A Jackie Hunter; Michael T Cheeseman; Steve D M Brown
Journal:  PLoS Genet       Date:  2006-10-06       Impact factor: 5.917

View more
  23 in total

1.  Lethal neonatal bone marrow failure syndrome with multiple congenital abnormalities, including limb defects, due to a constitutional deletion of 3' MECOM.

Authors:  Lars T van der Veken; Merel C Maiburg; Floris Groenendaal; Mariëlle E van Gijn; Andries C Bloem; Claudia Erpelinck; Stefan Gröschel; Mathijs A Sanders; Ruud Delwel; Marc B Bierings; Arjan Buijs
Journal:  Haematologica       Date:  2018-02-08       Impact factor: 9.941

2.  Expanding the phenotypic and genetic spectrum of radioulnar synostosis associated hematological disease.

Authors:  Amanda Walne; Hemanth Tummala; Alicia Ellison; Shirleny Cardoso; Jasmin Sidhu; Gabriela Sciuccati; Tom Vulliamy; Inderjeet Dokal
Journal:  Haematologica       Date:  2018-03-08       Impact factor: 9.941

Review 3.  Hereditary thrombocytopenias: a growing list of disorders.

Authors:  Patrizia Noris; Alessandro Pecci
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

4.  MDS1 and EVI1 complex locus (MECOM): a novel candidate gene for hereditary hematological malignancies.

Authors:  Tim Ripperger; Winfried Hofmann; Jan C Koch; Katayoon Shirneshan; Detlef Haase; Gerald Wulf; Peter R Issing; Matthias Karnebogen; Gunnar Schmidt; Bernd Auber; Brigitte Schlegelberger; Thomas Illig; Birgit Zirn; Doris Steinemann
Journal:  Haematologica       Date:  2017-11-02       Impact factor: 9.941

Review 5.  Hematopoietic transcription factor mutations: important players in inherited platelet defects.

Authors:  Natthapol Songdej; A Koneti Rao
Journal:  Blood       Date:  2017-04-17       Impact factor: 22.113

6.  Human Inborn Errors of Immunity: 2022 Update on the Classification from the International Union of Immunological Societies Expert Committee.

Authors:  Stuart G Tangye; Waleed Al-Herz; Aziz Bousfiha; Charlotte Cunningham-Rundles; Jose Luis Franco; Steven M Holland; Christoph Klein; Tomohiro Morio; Eric Oksenhendler; Capucine Picard; Anne Puel; Jennifer Puck; Mikko R J Seppänen; Raz Somech; Helen C Su; Kathleen E Sullivan; Troy R Torgerson; Isabelle Meyts
Journal:  J Clin Immunol       Date:  2022-06-24       Impact factor: 8.542

7.  MECOM-associated syndrome: a heterogeneous inherited bone marrow failure syndrome with amegakaryocytic thrombocytopenia.

Authors:  Manuela Germeshausen; Phil Ancliff; Jaime Estrada; Markus Metzler; Eva Ponstingl; Horst Rütschle; Dirk Schwabe; Richard H Scott; Sule Unal; Angela Wawer; Bernward Zeller; Matthias Ballmaier
Journal:  Blood Adv       Date:  2018-03-27

8.  A Pure 2-Mb 3q26.2 Duplication Proximal to the Critical Region of 3q Duplication Syndrome.

Authors:  Miriam Coelho Molck; Milena Simioni; Társis Paiva Vieira; Fabíola Paoli Monteiro; Vera L Gil-da-Silva-Lopes
Journal:  Mol Syndromol       Date:  2018-06-08

Review 9.  Inherited Platelet Disorders: An Updated Overview.

Authors:  Verónica Palma-Barqueros; Nuria Revilla; Ana Sánchez; Ana Zamora Cánovas; Agustín Rodriguez-Alén; Ana Marín-Quílez; José Ramón González-Porras; Vicente Vicente; María Luisa Lozano; José María Bastida; José Rivera
Journal:  Int J Mol Sci       Date:  2021-04-26       Impact factor: 5.923

Review 10.  Inherited platelet disorders: toward DNA-based diagnosis.

Authors:  Claire Lentaigne; Kathleen Freson; Michael A Laffan; Ernest Turro; Willem H Ouwehand
Journal:  Blood       Date:  2016-04-19       Impact factor: 25.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.